FHIRsmith: FHIR Resources

FHIR IG analytics

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | pt | se | stt | tw | uk | us | uv
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Authority Hl7

73,988 resources (JSON | CSV)

Type:
Text: Package: Only Show Used

By Version

R2: 0
R2B: 0
R3: 8,436
R4: 40,031
R4B: 11,108
R5: 13,752
R6: 661

By Realm

none: 4,083
au: 293
be: 440
ca: 440
ch: 1,529
cl: 519
cr: 88
cz: 869
de: 193
dk: 76
ee: 73
eu: 986
fi: 87
fr: 223
in: 29
it: 206
kr: 122
nl: 1,009
no: 26
nz: 49
pl: 245
pt: 22
se: 23
stt: 116
uk: 6
us: 19,368
uv: 42,832
other: 6

Start Prev Rows 40400 - 40600 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Usage #
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.262.json	ALK Negative (geneinterpretation) SNOMEDCT	active	2024-06	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.263.json	ALK Negative (geneinterpretation) NCI	active	2024-06	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.264.json	ALK Negative (geneinterpretation) SNOMEDCT NCI	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.265.json	Locoregional Sites	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.266.json	NSCLC N2 Stage	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.267.json	NSCLC N1 Stage	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.268.json	NSCLC N0 Stage	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.269.json	NSCLC T3_T4 Stage	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.27.json	Genetic Test Finding	active	2023-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.270.json	NSCLC T2 Stage	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.271.json	NSCLC T1 Stage	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.272.json	Locally_Advanced_Metastatic_NSCLC Stage Group	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.273.json	Localized_Inclusion_NSCLC Stage Group	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.274.json	Localized_Exclusion_NSCLC Stage Group	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.275.json	tarlatamab dlle	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.276.json	Extensive SCLC Stage Group SNOMEDCT	active	2024-06	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.277.json	Extensive SCLC Stage Group NCIM	active	2024-06	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.278.json	Extensive SCLC Stage Group	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.279.json	Localized SCLC Stage Group	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.280.json	SCLC M Stage (metastatic)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.281.json	SCLC T Stage	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.282.json	SCLC N Stage	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.283.json	SCLC histology (to include those patients)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.284.json	Binimetinib	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.285.json	Encorafenib	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.286.json	Encorafenib PM Molecular variant	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.288.json	BRAF Positive (geneinterpretation)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.289.json	BRAF test (HGNC)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.292.json	Prior therapy for Amivantamab	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.293.json	ENHERTU Drug	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.294.json	Metastatic_Solid_Cancer_Stage Group SNOMED CT	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.295.json	Locally_Advanced_Solid_Cancer_Stage Group SNOMED CT	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.296.json	Localized_Solid_Cancer_Stage Group SNOMED CT	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.297.json	Solid cancer M Stage (metastatic)	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.298.json	Solid Cancer T Stage	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.299.json	Solid Cancer N Stage	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.302.json	HER2_IHC_Positive	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.303.json	HER2 Negative (geneinterpretation/Labtestvalue) SNOMED	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.304.json	HER2 Negative (geneinterpretation/Labtestvalue) LOINC	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.305.json	HER2 Negative (geneinterpretation/Labtestvalue) NCI	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.307.json	HER2 Negative (geneinterpretation/Labtestvalue)	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.308.json	Solid Cancer Diagnosis ICD 9	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.309.json	Solid Cancer Diagnosis SNOMED CT	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.310.json	Solid Cancer Diagnosis	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.311.json	Localized_Solid_Cancer_Stage Group NCIM	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.313.json	Localized_Solid_Cancer_Stage Group	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.314.json	Locally_Advanced_Solid_Cancer_Stage Group NCIM	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.315.json	Locally_Advanced_Solid_Cancer_Stage Group	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.316.json	Metastatic_Solid_Cancer_Stage Group NCIM	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.317.json	Metastatic_Solid_Cancer_Stage Group	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.318.json	Solid Cancer T Stage LOINC	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.319.json	Solid Cancer T Stage NCI	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.320.json	Solid Cancer T Stage codes	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.321.json	Prior_Systemic_therapy_Enhertu	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.322.json	RET test_Solid_cancer (HGNC)	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.323.json	RET Positive_Solid_Cancer (geneinterpretation)	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.324.json	RET Negative_Solid_Cancer (geneinterpretation)	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.325.json	RET fusion Molecular Variants_Solid_Cancer	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.326.json	Prior_systemic_therapy_Retevmo	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.327.json	Selpercatinib (Retevmo) Drug	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.328.json	Breast Cancer Diagnosis ICD9	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.329.json	Breast Cancer Diagnosis ICD10	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.330.json	Breast Cancer Diagnosis	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.331.json	Metastatic_Breast_Cancer_Stage Group	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.332.json	Locally_Advanced_Breast_Cancer_Stage Group	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.333.json	Localized_Breast_Cancer_Stage Group	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.334.json	Breast cancer M Stage (metastatic)	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.335.json	Breast Cancer T Stage	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.336.json	Breast Cancer N Stage	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.337.json	Metastatic Sites All Breast SNOMEDCT	active	2024-09	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.338.json	Metastatic Sites All Breast ICD9	active	2024-09	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.339.json	Metastatic Sites All Breast ICD10	active	2024-09	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.340.json	Metastatic Sites All Breast (grouped, SNOMEDCT/ICD9/ICD10)	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.341.json	Aromatase_Inhibitor therapy	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.342.json	Capivasertib_therapy	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.343.json	Fulvestrant_therapy	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.344.json	PTEN_gene	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.345.json	PTEN_geneinterpretation	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.346.json	PIK3CA_gene	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.347.json	PI3KCA_geneinterpretation	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.348.json	AKTI_gene	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.349.json	AKTI_geneinterpretation	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.350.json	Progesterone_receptor_gene	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.351.json	Progesterone_receptor_geneinterpretation	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.352.json	Estrogen_receptor_gene	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.353.json	Estrogen_receptor_geneinterpretation	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.354.json	Progesterone_receptor_labtest	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.355.json	Progesterone_receptor_labinterpretation	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.356.json	Estrogen_receptor_labtest	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.357.json	Estrogen_receptor_labinterpretation	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.358.json	NSCLC M0 Stage	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.359.json	HER2_IHC_test_Gene	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.360.json	HER2_IHC_test_Lab	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.361.json	HER2_Fish_test	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.362.json	HER2_IHC_Negative	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.363.json	Trodelvy	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.364.json	Chemotherapy_breast_cancer	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.365.json	Cyclin_dependent_kinase	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.366.json	Taxane_Trodelvy	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.367.json	Endocrine_therapy	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.368.json	HER2_Fish_test_Negative	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.369.json	HER2_IHC_Equivocal	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.370.json	HER2 Positive_PM_results	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.371.json	HER2 test_Lab	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.372.json	HER2 test_gene	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.374.json	Thyroid Cancer Diagnosis	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.375.json	Metastatic_Thyroid_Stage Group	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.376.json	RET mutation_Molecular Variants	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.377.json	RET Gene mutation	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.378.json	Locally_Advanced_Localized_Thyroid_Cancer_Stage Group	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.379.json	Thyroid cancer M1_Stage	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.380.json	Thyroid_cancer_M0_Stage	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.381.json	Thyroid_cancer_T_Stage	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.382.json	Thyroid_cancer_T1_T2_T3_Stage	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.383.json	Thyroid_cancer_T4_Stage	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.384.json	Thyroid_cancer_N1b_Stage&Above	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.385.json	Thyroid_cancer_N_Stage	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.386.json	Medullary_thyroid_histology	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.387.json	RET test_Thyroid_cancer (HGNC)	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.388.json	RET Positive	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.389.json	NSCLC N3 Stage	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.390.json	CRC Cancer Diagnosis ICD9	active	2024-08	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.391.json	CRC Cancer Diagnosis ICD10	active	2024-08	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.392.json	CRC Cancer Diagnosis ICD9/ICD10	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.393.json	Metastatic_CRC_Cancer_Stage Group	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.394.json	Locally_Advanced_Localized_CRC_Stage Group	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.395.json	CRC cancer M Stage (metastatic)	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.396.json	CRC Cancer T Stage	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.397.json	CRC Cancer N Stage	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.398.json	KRAS_gene	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.399.json	KRAS_negative	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.40.json	Locoregional Breast Cancer	active	2023-10	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.400.json	Fluoropyrimidine_CRC	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.401.json	Oxaliplatin	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.402.json	Irinotecan_based_therapy	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.403.json	anti_VEGF_therapy_CRC	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.404.json	anti_EGFR_therapy_CRC	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.405.json	fruquitinib	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.406.json	Locally_Advanced_CRC_Stage Group	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.407.json	Localized_CRC_Stage Group	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.408.json	CRC cancer M0_Stage	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.409.json	CRC_Cancer_T1_Stage	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.410.json	CRC_Cancer_T2_Stage	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.411.json	CRC_Cancer_T3_Stage	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.412.json	CRC_Cancer_T4_Stage	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.413.json	CRC Cancer N1 Stage	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.414.json	CRC Cancer N2 Stage	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.415.json	CRC Cancer N2b Stage	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.416.json	KRAS_G12C_MV	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.417.json	KRAS_G12C_PM	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.418.json	KRAS_positive	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.419.json	Adagrasib	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.42.json	Breast Cancer	active	2023-10	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.420.json	cetuximab_therapy	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.421.json	Tamoxifen_therapy	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.423.json	Endometrial Cancer Diagnosis ICD 10	active	2024-09	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.425.json	Endometrial Cancer Diagnosis ICD9CM	active	2024-09	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.426.json	Endometrial Cancer Diagnosis	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.428.json	Localized_Endometerial_Stage Group SNOMED	active	2024-09	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.429.json	Localized_Endometerial_Stage Group NCIM	active	2024-09	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.431.json	Endometrial_Sarcoma_Tumor_Histology_exc	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.432.json	Endometrial cancer M Stage (metastatic)	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.433.json	Endometrial_M0_Stage	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.436.json	Prior_therapy_Endometrial	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.437.json	Paclitaxel_therapy	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.441.json	Carboplatin_therapy	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.442.json	Durvalumab_therapy	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.444.json	MMR_Gene_Lab_LOINC	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.447.json	MMR_Gene_HGNC	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.449.json	Endometrial_ Cancer N Stage	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.451.json	Endometrial_N0_Stage	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.453.json	Endometrial_N1_N2_Stage	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.455.json	Endometrial_T1_T3_Stage	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.456.json	Endometrial_T3_Stage	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.458.json	Endometrial_T4_Stage	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.459.json	Endometrial Cancer T Stage	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.46.json	Endometrial Cancer ICD10	active	2023-11	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.460.json	Localized_Endometerial_Stage Group_SNOMED/NCIM	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.461.json	Metastatic Sites All CRC	active	2024-09	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.462.json	Metastatic Sites All CRC ICD 10	active	2024-09	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.463.json	Metastatic Sites All CRC ICD 9	active	2024-09	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.464.json	Metastatic Sites All CRC (grouped, SNOMEDCT/ICD9/ICD10)	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.465.json	NTRK Repotrectinib Molecular Variants	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.466.json	NTRK_Gene_rearrangment	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.467.json	Prior_Systemic_therapy_Repotrectinib	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.468.json	NTRK_Positive	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.469.json	NTRK_test_gene	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.47.json	Systemic treatment for endometrial cancer	active	2023-11	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.470.json	Tamoxifen_Trodelvy	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.471.json	Toremifene_trodelvy	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.472.json	Fulvestrant_Trodelvy	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.473.json	Elacestrant	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.474.json	Anastrozole_Trodelvy	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.475.json	Leuprolide_Trodelvy	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.476.json	Abemaciclib	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.477.json	Palbociclib	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.478.json	Ribociclib	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.479.json	Carboplatin_Trodelvy	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.48.json	Endometrial Cancers	active	2023-11	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.480.json	Cisplatin_Trodelvy	active	2024-09	us